By Michael Cohick, Senior ETF Product Manager, VanEck Recent positive developments in COVID-19 vaccines have spurred a wave of market exuberance, lifting share prices of biotech companies at the forefront of the vaccine race. The broader NASDAQ Biotechnology Index has also benefited from the rally,...